Lancet Reg Health West Pac 2022;18
[3] Other common adverse effects reported during the clinical trials include back pain, upper respiratory tract infections, melanocyte naevus, decreased appetite, migraine, dizziness, weakness, fatigue, lethargy, sleepiness, hot flashes, abdominal pain, diarrhea, vomiting, flushing, development of warts, spots, and freckles, and itchy skin (between 1% and 10% of people)
This is precisely why we built Real Peptides around small-batch synthesis and exacting quality control
You may also like FAQs Everything you need to know about Tirzepatide how it works, what to expect, and how to get started with a licensed provider
What most articles get wrong about this: The pressure to finish right after hitting your goal weight can push patients toward surgery too early
Stoll S, Schweiger A